Cargando…
伊马替尼对慢性髓性白血病慢性期儿童身高的影响
OBJECTIVE: To evaluate the effect of imatinib on growth impairment in children with chronic myeloid leukemia (CML-CP) in the chronic phase. METHODS: From July 2018 to July 2019, questionnaires were distributed to CML children aged <18 years at the time of diagnosis who were receiving imatinib for...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449767/ https://www.ncbi.nlm.nih.gov/pubmed/32810960 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.07.003 |
Ejemplares similares
-
原研伊马替尼或尼洛替尼转换国产伊马替尼治疗慢性髓性白血病慢性期患者有效性、安全性和生活质量研究
Publicado: (2019) -
伊马替尼治疗初发慢性髓性白血病慢性期患者获得分子学反应的临床预测模型
Publicado: (2023) -
氟马替尼与伊马替尼治疗初发慢性髓性白血病慢性期患者的有效性及严重血液学不良反应发生率比较
Publicado: (2023) -
尼洛替尼与伊马替尼一线治疗初发慢性髓性白血病患者的比较研究
Publicado: (2019) -
国产甲磺酸伊马替尼治疗慢性髓性白血病慢性期早期疗效和安全性的前瞻性、多中心临床研究
Publicado: (2015)